NasdaqGM:ANIPPharmaceuticals
ANI Pharmaceuticals (ANIP) Recalls HydrOXYzine Solution, Is The Pullback A Valuation Opportunity?
Recall event puts product quality in focus for ANI Pharmaceuticals stock
ANI Pharmaceuticals (ANIP) has voluntarily initiated a nationwide Class III recall of a specific lot of its hydrOXYzine Hydrochloride Oral Solution after detection of a foreign substance, drawing attention to its product quality controls.
See our latest analysis for ANI Pharmaceuticals.
ANI Pharmaceuticals' share price has eased in the very short term, with a 1-day share price return of 1.17% down and a 7-day share price...